Two-year results with 166Holmium-phytate treatment of chronic synovitis.: Phase I-IIa, randomized, increasing dosage, single-blind, placebo-controlled comparative study

被引：0
|
作者：
Szentesi, M
Takács, S
Farbaky, Z
Nagy, E
Környei, J
Antalffy, M
Törkö, J
Tóth, G
Jánoki, G
Balogh, L
Géher, P
机构：
[1] Semmelweis Univ, H-1085 Budapest, Hungary
[2] Inst Isotopes Co Ltd, Budapest, Hungary
[3] Natl FJC Res Inst Radiobiol & Radiohyg, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [41] Single oral treatment with the 5-HT1A/B agonist, eltoprazine, counteracts L-dopa-induced dyskinesias in Parkinson's disease: A phase I/IIA, double-blind, randomized, placebo-controlled, dose-finding study
    Svenningsson, P.
    Rosenblad, C.
    Arvidsson, K. af Edholm
    Wictorin, K.
    Keywood, C.
    Shankar, B.
    Lowe, D. A.
    Bjorklund, A.
    Widner, H.
    MOVEMENT DISORDERS, 2015, 30 : S130 - S130
  • [42] Lusutrombopag for Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Who Are Undergoing Non-Emergency Invasive Procedures: Results from An International Phase 3, Randomized, Double-Blind, Placebo-Controlled Study (L-PLUS 2)
    Afdhal, Nezam H.
    Duggal, Ajay
    Ochiai, Toshimitsu
    Motomiya, Tomoko
    Kano, Takeshi
    Nagata, Tsutae
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2017, 66 (06) : 1254A - 1254A
  • [43] Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects
    Huntjens, Dymphy R. H.
    Ouwerkerk-Mahadevan, Sivi
    Brochot, Anne
    Rusch, Sarah
    Stevens, Marita
    Verloes, Rene
    CLINICAL PHARMACOKINETICS, 2017, 56 (11) : 1331 - 1342
  • [44] Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects
    Dymphy R. H. Huntjens
    Sivi Ouwerkerk-Mahadevan
    Anne Brochot
    Sarah Rusch
    Marita Stevens
    Rene Verloes
    Clinical Pharmacokinetics, 2017, 56 : 1331 - 1342
  • [45] Safety profile and signal of efficacy of a non-fcr-binding, fully human anti-Cd3 monoclonal antibody in patients with moderate to severe Crohn's disease- results of a phase I/Iia, double blind, placebo-controlled, randomized, dose escalation study
    van der Woude, Christien J.
    Stokkers, Pieter C.
    van Bodegraven, Ad A.
    Van Assche, Gert A.
    Hebzda, Zbigniew
    Paradowski, Leszek
    D'Haens, Geert
    Ghosh, Subrata
    Feagan, Brian
    Rutgeerts, Paul J.
    Dijkstra, Gerard
    De Jong, Dirk J.
    Oldenburg, Bas
    Farhan, Mahdi
    Dean, Yann
    Hommes, Daniel W.
    GASTROENTEROLOGY, 2008, 134 (04) : A67 - A67
  • [46] Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, for Treatment of Rheumatoid Arthritis With an Inadequate Response to One or More Disease-Modifying Antirheumatic Drugs Results of a Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study
    Ostergaard, Mikkel
    Baslund, Bo
    Rigby, William
    Rojkovich, Bernadette
    Jorgensen, Christian
    Dawes, Peter T.
    Wiell, Charlotte
    Wallace, Daniel J.
    Tamer, Soren C.
    Kastberg, Helle
    Petersen, Jorgen
    Sierakowski, Stanislaw
    ARTHRITIS AND RHEUMATISM, 2010, 62 (08): : 2227 - 2238
  • [47] Pharmacokinetics of Two 6-Day Frovatriptan Dosing Regimens Used for the Short-Term Prevention of Menstrual MigraineA Phase I, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Single-Centre Study in Healthy Female Volunteers
    Andrew Wade
    Stephen Pawsey
    Holly Whale
    Malcolm Boyce
    Steve Warrington
    Clinical Drug Investigation, 2009, 29 : 325 - 337
  • [48] Pharmacokinetics of Two 6-Day Frovatriptan Dosing Regimens Used for the Short-Term Prevention of Menstrual Migraine A Phase I. Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Single-Centre Study in Healthy Female Volunteers
    Wade, Andrew
    Pawsey, Stephen
    Whale, Holly
    Boyce, Malcolm
    Warrington, Steve
    CLINICAL DRUG INVESTIGATION, 2009, 29 (05) : 325 - 337
  • [49] Interim results from a randomized, double-blind, placebo-controlled phase 1b study in subjects with chronic HCV after treatment with GI-5005, a yeast-based HCV immunotherapy targeting NS3 and core proteins
    Everson, Gregory T.
    Tong, Myron J.
    Jacobson, Ira M.
    Jensen, Donald M.
    Haller, Aurelia A.
    Lauer, Georg M.
    Parker, Joanne
    Ferraro, John
    Cruickshank, Scott E.
    Duke, Richard C.
    Apelian, David
    Rodell, Timothy C.
    Schiff, Eugene R.
    HEPATOLOGY, 2006, 44 (04) : 697A - 698A
  • [50] A phase II randomized, placebo-controlled, single-blind, multi-center dose-escalation study to evaluate tolerability, safety, pharmacokinetics, and pharimacodynamics of a single intravenous administration of INO-1001 in subjects with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention: Results of the TIMI 37A trial
    Morrow, David A.
    Baran, Kenneth
    Krakover, Ricardo
    Dauerman, Harold
    Murphy, Sabina A.
    Kumar, Sujatha
    McCabe, Carolyn H.
    Brickman, Chaim M.
    Salzman, Andrew L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 202A - 202A
12345